

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | central nervous system myelination (GO:0022010) | 6.09201007 |
| 2 | axon ensheathment in central nervous system (GO:0032291) | 6.09201007 |
| 3 | fatty acid elongation (GO:0030497) | 5.50246444 |
| 4 | negative regulation of erythrocyte differentiation (GO:0045647) | 5.02048544 |
| 5 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.62608090 |
| 6 | long-chain fatty acid biosynthetic process (GO:0042759) | 4.37771408 |
| 7 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.36468533 |
| 8 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.33519318 |
| 9 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.15912317 |
| 10 | response to peptidoglycan (GO:0032494) | 4.09337659 |
| 11 | mannose metabolic process (GO:0006013) | 4.02776389 |
| 12 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.98347525 |
| 13 | negative regulation of cell killing (GO:0031342) | 3.98347525 |
| 14 | nucleotide transmembrane transport (GO:1901679) | 3.92108591 |
| 15 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.83216301 |
| 16 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.83216301 |
| 17 | modulation by symbiont of host immune response (GO:0052553) | 3.83216301 |
| 18 | positive regulation by symbiont of host defense response (GO:0052509) | 3.83216301 |
| 19 | modulation by symbiont of host defense response (GO:0052031) | 3.83216301 |
| 20 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.83216301 |
| 21 | neutrophil activation involved in immune response (GO:0002283) | 3.82077138 |
| 22 | polyol transport (GO:0015791) | 3.69804980 |
| 23 | limb bud formation (GO:0060174) | 3.68326396 |
| 24 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.67787831 |
| 25 | macrophage activation involved in immune response (GO:0002281) | 3.66056352 |
| 26 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.62132936 |
| 27 | regulation of gamma-delta T cell activation (GO:0046643) | 3.55307773 |
| 28 | detection of bacterium (GO:0016045) | 3.54444587 |
| 29 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.53900416 |
| 30 | immunoglobulin mediated immune response (GO:0016064) | 3.53848311 |
| 31 | detection of other organism (GO:0098543) | 3.51873598 |
| 32 | response to muramyl dipeptide (GO:0032495) | 3.41761318 |
| 33 | positive regulation of cellular amine metabolic process (GO:0033240) | 3.39843906 |
| 34 | negative regulation of interleukin-12 production (GO:0032695) | 3.30192714 |
| 35 | germinal center formation (GO:0002467) | 3.29379117 |
| 36 | myelination (GO:0042552) | 3.28863567 |
| 37 | axon ensheathment (GO:0008366) | 3.27663349 |
| 38 | ensheathment of neurons (GO:0007272) | 3.27663349 |
| 39 | glycerophospholipid catabolic process (GO:0046475) | 3.26106198 |
| 40 | regulation of mast cell degranulation (GO:0043304) | 3.26005960 |
| 41 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.25951810 |
| 42 | regulation of leukocyte degranulation (GO:0043300) | 3.25862208 |
| 43 | positive regulation of B cell differentiation (GO:0045579) | 3.24837632 |
| 44 | NIK/NF-kappaB signaling (GO:0038061) | 3.24771019 |
| 45 | GPI anchor biosynthetic process (GO:0006506) | 3.23056793 |
| 46 | glycosphingolipid catabolic process (GO:0046479) | 3.22990669 |
| 47 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 3.21876583 |
| 48 | presynaptic membrane assembly (GO:0097105) | 3.21408894 |
| 49 | dopamine biosynthetic process (GO:0042416) | 3.20888565 |
| 50 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.18276715 |
| 51 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.17809101 |
| 52 | L-phenylalanine catabolic process (GO:0006559) | 3.17809101 |
| 53 | keratinocyte development (GO:0003334) | 3.14954703 |
| 54 | cholesterol biosynthetic process (GO:0006695) | 3.14251099 |
| 55 | presynaptic membrane organization (GO:0097090) | 3.14091860 |
| 56 | GPI anchor metabolic process (GO:0006505) | 3.13414726 |
| 57 | detection of external biotic stimulus (GO:0098581) | 3.08514608 |
| 58 | isoprenoid biosynthetic process (GO:0008299) | 3.07451796 |
| 59 | response to type I interferon (GO:0034340) | 3.07024710 |
| 60 | type I interferon signaling pathway (GO:0060337) | 3.06591408 |
| 61 | cellular response to type I interferon (GO:0071357) | 3.06591408 |
| 62 | pinocytosis (GO:0006907) | 3.04585626 |
| 63 | photoreceptor cell differentiation (GO:0046530) | 3.04583222 |
| 64 | eye photoreceptor cell differentiation (GO:0001754) | 3.04583222 |
| 65 | positive thymic T cell selection (GO:0045059) | 3.01092883 |
| 66 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.01000196 |
| 67 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.00080546 |
| 68 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.97110624 |
| 69 | response to redox state (GO:0051775) | 2.95832418 |
| 70 | negative regulation of neurotransmitter transport (GO:0051589) | 2.95428931 |
| 71 | B cell receptor signaling pathway (GO:0050853) | 2.92854372 |
| 72 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.92085966 |
| 73 | glycolipid catabolic process (GO:0019377) | 2.89818545 |
| 74 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.87296545 |
| 75 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.86179739 |
| 76 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.85675251 |
| 77 | superoxide anion generation (GO:0042554) | 2.83011716 |
| 78 | import into cell (GO:0098657) | 2.81223941 |
| 79 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.81149218 |
| 80 | oligosaccharide catabolic process (GO:0009313) | 2.80841563 |
| 81 | regulation of superoxide anion generation (GO:0032928) | 2.79522576 |
| 82 | defense response to protozoan (GO:0042832) | 2.79370612 |
| 83 | very long-chain fatty acid metabolic process (GO:0000038) | 2.79018627 |
| 84 | sterol biosynthetic process (GO:0016126) | 2.78370468 |
| 85 | L-phenylalanine metabolic process (GO:0006558) | 2.78029727 |
| 86 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.78029727 |
| 87 | nucleotide transport (GO:0006862) | 2.77597256 |
| 88 | detection of molecule of bacterial origin (GO:0032490) | 2.77387390 |
| 89 | oligodendrocyte differentiation (GO:0048709) | 2.77331730 |
| 90 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.77107369 |
| 91 | response to protozoan (GO:0001562) | 2.76777382 |
| 92 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.76527410 |
| 93 | detection of biotic stimulus (GO:0009595) | 2.75847390 |
| 94 | negative regulation of protein localization to cell surface (GO:2000009) | 2.75828814 |
| 95 | regulation of antigen processing and presentation (GO:0002577) | 2.74901562 |
| 96 | negative regulation of innate immune response (GO:0045824) | 2.74496267 |
| 97 | cranial nerve development (GO:0021545) | 2.73595109 |
| 98 | aromatic amino acid family catabolic process (GO:0009074) | 2.72610181 |
| 99 | peptide catabolic process (GO:0043171) | 2.71221944 |
| 100 | regulation of necroptotic process (GO:0060544) | 2.70563221 |
| 101 | neuron remodeling (GO:0016322) | 2.70028892 |
| 102 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.69481113 |
| 103 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.69364109 |
| 104 | mannosylation (GO:0097502) | 2.69335673 |
| 105 | response to thyroid hormone (GO:0097066) | 2.67127329 |
| 106 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.64774017 |
| 107 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.64696346 |
| 108 | positive regulation of action potential (GO:0045760) | 2.64586461 |
| 109 | purine ribonucleotide transport (GO:0015868) | 2.64543628 |
| 110 | peptide biosynthetic process (GO:0043043) | 2.64463054 |
| 111 | cellular extravasation (GO:0045123) | 2.63470174 |
| 112 | myeloid cell activation involved in immune response (GO:0002275) | 2.62835955 |
| 113 | glutathione biosynthetic process (GO:0006750) | 2.62750323 |
| 114 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.60920926 |
| 115 | response to host immune response (GO:0052572) | 2.60920926 |
| 116 | ATP synthesis coupled proton transport (GO:0015986) | 2.60100515 |
| 117 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.60100515 |
| 118 | positive regulation of antigen processing and presentation (GO:0002579) | 2.59895198 |
| 119 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.58962692 |
| 120 | myeloid dendritic cell differentiation (GO:0043011) | 2.58509046 |
| 121 | regulation of B cell differentiation (GO:0045577) | 2.58138969 |
| 122 | catecholamine biosynthetic process (GO:0042423) | 2.57912910 |
| 123 | catechol-containing compound biosynthetic process (GO:0009713) | 2.57912910 |
| 124 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.57864694 |
| 125 | regulation of regulated secretory pathway (GO:1903305) | 2.57719061 |
| 126 | respiratory electron transport chain (GO:0022904) | 2.57711159 |
| 127 | negative regulation of myoblast differentiation (GO:0045662) | 2.57674996 |
| 128 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.57357320 |
| 129 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.55607768 |
| 130 | regulation of necrotic cell death (GO:0010939) | 2.55585026 |
| 131 | positive regulation of histone deacetylation (GO:0031065) | 2.53202517 |
| 132 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.52825931 |
| 133 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.51752035 |
| 134 | N-acetylneuraminate metabolic process (GO:0006054) | 2.50890216 |
| 135 | sphingoid metabolic process (GO:0046519) | 2.50403994 |
| 136 | cellular copper ion homeostasis (GO:0006878) | 2.50231883 |
| 137 | negative regulation of granulocyte differentiation (GO:0030853) | 2.49948553 |
| 138 | retina layer formation (GO:0010842) | 2.49713265 |
| 139 | modulation by symbiont of host cellular process (GO:0044068) | 2.49223797 |
| 140 | negative regulation of interleukin-6 production (GO:0032715) | 2.49206949 |
| 141 | electron transport chain (GO:0022900) | 2.49086268 |
| 142 | negative regulation of necroptotic process (GO:0060546) | 2.48284376 |
| 143 | leukocyte aggregation (GO:0070486) | 2.47710658 |
| 144 | positive regulation of protein kinase C signaling (GO:0090037) | 2.47422222 |
| 145 | response to host (GO:0075136) | 2.46906572 |
| 146 | response to host defenses (GO:0052200) | 2.46906572 |
| 147 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.46906572 |
| 148 | thymic T cell selection (GO:0045061) | 2.45029364 |
| 149 | macrophage activation (GO:0042116) | 2.44855549 |
| 150 | amine catabolic process (GO:0009310) | 2.44794284 |
| 151 | cellular biogenic amine catabolic process (GO:0042402) | 2.44794284 |
| 152 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 2.43744022 |
| 153 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 2.43744022 |
| 154 | positive regulation of type 2 immune response (GO:0002830) | 2.43361858 |
| 155 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.42678083 |
| 156 | L-amino acid import (GO:0043092) | 2.42084558 |
| 157 | barbed-end actin filament capping (GO:0051016) | 2.41759166 |
| 158 | granulocyte activation (GO:0036230) | 2.41164486 |
| 159 | myeloid dendritic cell activation (GO:0001773) | 2.40857029 |
| 160 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.40781731 |
| 161 | neutrophil activation (GO:0042119) | 2.39885585 |
| 162 | modulation by virus of host process (GO:0019054) | 2.39830202 |
| 163 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.39618210 |
| 164 | B cell mediated immunity (GO:0019724) | 2.39474337 |
| 165 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.39164049 |
| 166 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.39023650 |
| 167 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.38566909 |
| 168 | T cell selection (GO:0045058) | 2.38307481 |
| 169 | amino sugar catabolic process (GO:0046348) | 2.36642397 |
| 170 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 2.36279556 |
| 171 | response to lipoprotein particle (GO:0055094) | 2.35547572 |
| 172 | organ growth (GO:0035265) | 2.34831297 |
| 173 | glutathione derivative metabolic process (GO:1901685) | 2.34266587 |
| 174 | glutathione derivative biosynthetic process (GO:1901687) | 2.34266587 |
| 175 | amyloid precursor protein metabolic process (GO:0042982) | 2.34097534 |
| 176 | negative regulation of transcription by competitive promoter binding (GO:0010944) | 2.32742791 |
| 177 | aldehyde catabolic process (GO:0046185) | 2.28198438 |
| 178 | proteasome assembly (GO:0043248) | 2.28027625 |
| 179 | sphingosine metabolic process (GO:0006670) | 2.26857539 |
| 180 | regulation of timing of cell differentiation (GO:0048505) | 2.26828449 |
| 181 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 2.26325243 |
| 182 | indole-containing compound catabolic process (GO:0042436) | 2.25044780 |
| 183 | indolalkylamine catabolic process (GO:0046218) | 2.25044780 |
| 184 | tryptophan catabolic process (GO:0006569) | 2.25044780 |
| 185 | protein neddylation (GO:0045116) | 2.23016235 |
| 186 | purine nucleotide transport (GO:0015865) | 2.21979654 |
| 187 | magnesium ion transport (GO:0015693) | 2.21842717 |
| 188 | aromatic amino acid family metabolic process (GO:0009072) | 2.21366472 |
| 189 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.21018194 |
| 190 | regulation of collateral sprouting (GO:0048670) | 2.20814271 |
| 191 | dopamine transport (GO:0015872) | 2.20112894 |
| 192 | alkaloid metabolic process (GO:0009820) | 2.19944081 |
| 193 | androgen biosynthetic process (GO:0006702) | 2.19050738 |
| 194 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.18824450 |
| 195 | ceramide catabolic process (GO:0046514) | 2.18765254 |
| 196 | tryptophan metabolic process (GO:0006568) | 2.18698294 |
| 197 | copper ion homeostasis (GO:0055070) | 2.18594405 |
| 198 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.18412560 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.82365328 |
| 2 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.29781339 |
| 3 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.19601113 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.16326093 |
| 5 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.87199989 |
| 6 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.76161682 |
| 7 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.65167057 |
| 8 | MYC_22102868_ChIP-Seq_BL_Human | 2.64796737 |
| 9 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.55997215 |
| 10 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.52846414 |
| 11 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.43145524 |
| 12 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.37910790 |
| 13 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.36755617 |
| 14 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.35469074 |
| 15 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.34694609 |
| 16 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.27913970 |
| 17 | VDR_22108803_ChIP-Seq_LS180_Human | 2.26826839 |
| 18 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.19062091 |
| 19 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.17800648 |
| 20 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.15224935 |
| 21 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.13703250 |
| 22 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.10665283 |
| 23 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.07697864 |
| 24 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.05902824 |
| 25 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.05701093 |
| 26 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.03183793 |
| 27 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.00848108 |
| 28 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.00507435 |
| 29 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.99931434 |
| 30 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.98136418 |
| 31 | MAF_26560356_Chip-Seq_TH1_Human | 1.94258693 |
| 32 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.93620738 |
| 33 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.92458201 |
| 34 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.91488233 |
| 35 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.90379820 |
| 36 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.90379695 |
| 37 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.89509233 |
| 38 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.89187422 |
| 39 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.88853650 |
| 40 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.83441803 |
| 41 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.81182422 |
| 42 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.80616566 |
| 43 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.79517435 |
| 44 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.78965481 |
| 45 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.78740394 |
| 46 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.77567413 |
| 47 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.76275499 |
| 48 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.75886671 |
| 49 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.72885325 |
| 50 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.72341037 |
| 51 | UTX_26944678_Chip-Seq_JUKART_Human | 1.70248458 |
| 52 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.69995149 |
| 53 | SPI1_23127762_ChIP-Seq_K562_Human | 1.69803177 |
| 54 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.69563026 |
| 55 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.68860257 |
| 56 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.68606779 |
| 57 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.68536082 |
| 58 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.66851652 |
| 59 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.65815532 |
| 60 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.65123414 |
| 61 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.63745789 |
| 62 | * MAF_26560356_Chip-Seq_TH2_Human | 1.63503147 |
| 63 | P300_19829295_ChIP-Seq_ESCs_Human | 1.63471267 |
| 64 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.61812935 |
| 65 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.61677210 |
| 66 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.61058006 |
| 67 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.60823139 |
| 68 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.59925208 |
| 69 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.58850437 |
| 70 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.57950331 |
| 71 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.57384728 |
| 72 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.56952553 |
| 73 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.56854017 |
| 74 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.56785229 |
| 75 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56506358 |
| 76 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.55620573 |
| 77 | P68_20966046_ChIP-Seq_HELA_Human | 1.55346433 |
| 78 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.55086529 |
| 79 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.54861262 |
| 80 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.54675725 |
| 81 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.54598858 |
| 82 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.54587579 |
| 83 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.54547121 |
| 84 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.53260191 |
| 85 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.52467160 |
| 86 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.50189380 |
| 87 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.49800078 |
| 88 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.49368561 |
| 89 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.44875377 |
| 90 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.44532860 |
| 91 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.43674636 |
| 92 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.42251147 |
| 93 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.42073185 |
| 94 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.41907013 |
| 95 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.40847527 |
| 96 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.40843932 |
| 97 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.40755018 |
| 98 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.40453488 |
| 99 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.40246589 |
| 100 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.39986318 |
| 101 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.39982260 |
| 102 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.38063492 |
| 103 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.36903333 |
| 104 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.36522453 |
| 105 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.36470922 |
| 106 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.35851383 |
| 107 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.35544770 |
| 108 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.34889121 |
| 109 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.34740841 |
| 110 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.34740841 |
| 111 | FUS_26573619_Chip-Seq_HEK293_Human | 1.34227276 |
| 112 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.34035049 |
| 113 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.33626855 |
| 114 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.32677641 |
| 115 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.32404705 |
| 116 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.31868680 |
| 117 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.30794371 |
| 118 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.29403198 |
| 119 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.29059671 |
| 120 | KDM2B_26808549_Chip-Seq_K562_Human | 1.28480584 |
| 121 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.27905439 |
| 122 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.27432564 |
| 123 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.27123375 |
| 124 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.26589158 |
| 125 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.26387405 |
| 126 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.26109930 |
| 127 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.25697459 |
| 128 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.25549706 |
| 129 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.25387333 |
| 130 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.24854498 |
| 131 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.24527965 |
| 132 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.24449572 |
| 133 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.24422299 |
| 134 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.24203940 |
| 135 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24147055 |
| 136 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.23532486 |
| 137 | GATA1_19941826_ChIP-Seq_K562_Human | 1.23510605 |
| 138 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.23395494 |
| 139 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.22525936 |
| 140 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.21982197 |
| 141 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.21904310 |
| 142 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.21312011 |
| 143 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.21299259 |
| 144 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.21192614 |
| 145 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20949895 |
| 146 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.20680605 |
| 147 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.19890418 |
| 148 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.19762602 |
| 149 | MYB_26560356_Chip-Seq_TH1_Human | 1.19745616 |
| 150 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.19576300 |
| 151 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.19379582 |
| 152 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.19294050 |
| 153 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.19212290 |
| 154 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.17749287 |
| 155 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.17175924 |
| 156 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.15995698 |
| 157 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.15948109 |
| 158 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.15747138 |
| 159 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.14537593 |
| 160 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.14411106 |
| 161 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.13496898 |
| 162 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.13335749 |
| 163 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.13027292 |
| 164 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.12787159 |
| 165 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.12498882 |
| 166 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.12072426 |
| 167 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.11876592 |
| 168 | MYB_26560356_Chip-Seq_TH2_Human | 1.11424513 |
| 169 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.11151386 |
| 170 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10470731 |
| 171 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.09621523 |
| 172 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.09021364 |
| 173 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.08308670 |
| 174 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.07278632 |
| 175 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06893991 |
| 176 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.06333727 |
| 177 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.06227893 |
| 178 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05984106 |
| 179 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.05591698 |
| 180 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.05002173 |
| 181 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.04985529 |
| 182 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.04953954 |
| 183 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.04324321 |
| 184 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.04324321 |
| 185 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.04324321 |
| 186 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.04009751 |
| 187 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.03987265 |
| 188 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.03943115 |
| 189 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.03659592 |
| 190 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.03253177 |
| 191 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.02222763 |
| 192 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.02135842 |
| 193 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.01230380 |
| 194 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.00792621 |
| 195 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.00723859 |
| 196 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.00616296 |
| 197 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.00616296 |
| 198 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.00484227 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 3.50618076 |
| 2 | MP0003436_decreased_susceptibility_to | 3.50169759 |
| 3 | MP0003136_yellow_coat_color | 3.39306537 |
| 4 | MP0003195_calcinosis | 3.28582795 |
| 5 | MP0005451_abnormal_body_composition | 3.01409024 |
| 6 | MP0000566_synostosis | 2.97439429 |
| 7 | MP0001835_abnormal_antigen_presentation | 2.96717501 |
| 8 | MP0000920_abnormal_myelination | 2.77610550 |
| 9 | MP0004381_abnormal_hair_follicle | 2.68781194 |
| 10 | MP0002419_abnormal_innate_immunity | 2.57450181 |
| 11 | MP0003300_gastrointestinal_ulcer | 2.55708205 |
| 12 | MP0008260_abnormal_autophagy | 2.50597430 |
| 13 | MP0001790_abnormal_immune_system | 2.47337999 |
| 14 | MP0005387_immune_system_phenotype | 2.47337999 |
| 15 | MP0005025_abnormal_response_to | 2.44053214 |
| 16 | MP0000685_abnormal_immune_system | 2.43777334 |
| 17 | MP0005000_abnormal_immune_tolerance | 2.41255616 |
| 18 | MP0003191_abnormal_cellular_cholesterol | 2.32362991 |
| 19 | MP0001188_hyperpigmentation | 2.24100878 |
| 20 | MP0001800_abnormal_humoral_immune | 2.21241024 |
| 21 | MP0002148_abnormal_hypersensitivity_rea | 2.18122282 |
| 22 | MP0006292_abnormal_olfactory_placode | 2.16881186 |
| 23 | MP0009278_abnormal_bone_marrow | 2.16783802 |
| 24 | MP0009785_altered_susceptibility_to | 2.16120347 |
| 25 | MP0004742_abnormal_vestibular_system | 2.10071706 |
| 26 | MP0002723_abnormal_immune_serum | 2.08804142 |
| 27 | MP0005171_absent_coat_pigmentation | 2.08585289 |
| 28 | MP0005464_abnormal_platelet_physiology | 2.07046299 |
| 29 | MP0002452_abnormal_antigen_presenting | 2.07006033 |
| 30 | MP0005409_darkened_coat_color | 2.06018778 |
| 31 | MP0001905_abnormal_dopamine_level | 2.05019455 |
| 32 | MP0002102_abnormal_ear_morphology | 2.03371996 |
| 33 | MP0005671_abnormal_response_to | 2.02151043 |
| 34 | MP0003718_maternal_effect | 2.00765987 |
| 35 | MP0002420_abnormal_adaptive_immunity | 1.97346346 |
| 36 | MP0001819_abnormal_immune_cell | 1.95191360 |
| 37 | MP0004043_abnormal_pH_regulation | 1.94715680 |
| 38 | MP0005670_abnormal_white_adipose | 1.93460738 |
| 39 | MP0005360_urolithiasis | 1.89590837 |
| 40 | MP0003183_abnormal_peptide_metabolism | 1.88413537 |
| 41 | MP0002139_abnormal_hepatobiliary_system | 1.85546675 |
| 42 | MP0002277_abnormal_respiratory_mucosa | 1.82862376 |
| 43 | MP0001986_abnormal_taste_sensitivity | 1.80078304 |
| 44 | MP0001661_extended_life_span | 1.78485848 |
| 45 | MP0001533_abnormal_skeleton_physiology | 1.78127992 |
| 46 | MP0002876_abnormal_thyroid_physiology | 1.77629025 |
| 47 | MP0009333_abnormal_splenocyte_physiolog | 1.77286181 |
| 48 | MP0005332_abnormal_amino_acid | 1.75994506 |
| 49 | MP0003763_abnormal_thymus_physiology | 1.75236917 |
| 50 | MP0005408_hypopigmentation | 1.72854987 |
| 51 | MP0010155_abnormal_intestine_physiology | 1.67985305 |
| 52 | MP0003075_altered_response_to | 1.66085343 |
| 53 | MP0004947_skin_inflammation | 1.65582285 |
| 54 | MP0010386_abnormal_urinary_bladder | 1.64382391 |
| 55 | MP0003950_abnormal_plasma_membrane | 1.63442879 |
| 56 | MP0004142_abnormal_muscle_tone | 1.61896276 |
| 57 | MP0003880_abnormal_central_pattern | 1.60976021 |
| 58 | MP0001845_abnormal_inflammatory_respons | 1.58316105 |
| 59 | MP0002405_respiratory_system_inflammati | 1.57882721 |
| 60 | MP0000604_amyloidosis | 1.51627408 |
| 61 | MP0000716_abnormal_immune_system | 1.51308173 |
| 62 | MP0003690_abnormal_glial_cell | 1.50765915 |
| 63 | MP0001545_abnormal_hematopoietic_system | 1.49192590 |
| 64 | MP0005397_hematopoietic_system_phenotyp | 1.49192590 |
| 65 | MP0005058_abnormal_lysosome_morphology | 1.49178645 |
| 66 | MP0002396_abnormal_hematopoietic_system | 1.48983435 |
| 67 | MP0002398_abnormal_bone_marrow | 1.48098233 |
| 68 | MP0008469_abnormal_protein_level | 1.47541431 |
| 69 | MP0002998_abnormal_bone_remodeling | 1.47072443 |
| 70 | MP0009840_abnormal_foam_cell | 1.46582138 |
| 71 | MP0006276_abnormal_autonomic_nervous | 1.46346029 |
| 72 | MP0003724_increased_susceptibility_to | 1.45624437 |
| 73 | MP0005645_abnormal_hypothalamus_physiol | 1.45512552 |
| 74 | MP0002638_abnormal_pupillary_reflex | 1.45437927 |
| 75 | MP0000858_altered_metastatic_potential | 1.38950775 |
| 76 | MP0001486_abnormal_startle_reflex | 1.36549870 |
| 77 | MP0005085_abnormal_gallbladder_physiolo | 1.35064782 |
| 78 | MP0001346_abnormal_lacrimal_gland | 1.35064185 |
| 79 | MP0004019_abnormal_vitamin_homeostasis | 1.33256330 |
| 80 | MP0001963_abnormal_hearing_physiology | 1.30882850 |
| 81 | MP0000026_abnormal_inner_ear | 1.30712620 |
| 82 | MP0001529_abnormal_vocalization | 1.27858973 |
| 83 | MP0002429_abnormal_blood_cell | 1.27179734 |
| 84 | MP0001485_abnormal_pinna_reflex | 1.27039667 |
| 85 | MP0004510_myositis | 1.25942926 |
| 86 | MP0000689_abnormal_spleen_morphology | 1.25749176 |
| 87 | MP0000343_altered_response_to | 1.23451617 |
| 88 | MP0003329_amyloid_beta_deposits | 1.21834119 |
| 89 | MP0000015_abnormal_ear_pigmentation | 1.21795178 |
| 90 | MP0002722_abnormal_immune_system | 1.20907765 |
| 91 | MP0001873_stomach_inflammation | 1.18505232 |
| 92 | MP0005379_endocrine/exocrine_gland_phen | 1.18170004 |
| 93 | MP0001853_heart_inflammation | 1.17444611 |
| 94 | MP0005084_abnormal_gallbladder_morpholo | 1.16125581 |
| 95 | MP0002272_abnormal_nervous_system | 1.15178420 |
| 96 | MP0008875_abnormal_xenobiotic_pharmacok | 1.14689072 |
| 97 | MP0001849_ear_inflammation | 1.14201508 |
| 98 | MP0000462_abnormal_digestive_system | 1.13527749 |
| 99 | MP0002735_abnormal_chemical_nociception | 1.12190730 |
| 100 | MP0005365_abnormal_bile_salt | 1.10199062 |
| 101 | MP0009764_decreased_sensitivity_to | 1.10100581 |
| 102 | MP0002295_abnormal_pulmonary_circulatio | 1.09179832 |
| 103 | MP0000538_abnormal_urinary_bladder | 1.08880098 |
| 104 | MP0005166_decreased_susceptibility_to | 1.06749313 |
| 105 | MP0003866_abnormal_defecation | 1.04795596 |
| 106 | MP0002132_abnormal_respiratory_system | 1.04749157 |
| 107 | MP0002933_joint_inflammation | 1.04031558 |
| 108 | MP0003938_abnormal_ear_development | 1.03574402 |
| 109 | MP0005551_abnormal_eye_electrophysiolog | 1.02391441 |
| 110 | MP0000383_abnormal_hair_follicle | 1.01746073 |
| 111 | MP0002098_abnormal_vibrissa_morphology | 1.01313161 |
| 112 | MP0000465_gastrointestinal_hemorrhage | 1.00775300 |
| 113 | MP0003186_abnormal_redox_activity | 0.99637174 |
| 114 | MP0003172_abnormal_lysosome_physiology | 0.99168994 |
| 115 | MP0009379_abnormal_foot_pigmentation | 0.98559751 |
| 116 | MP0001502_abnormal_circadian_rhythm | 0.98177213 |
| 117 | MP0002229_neurodegeneration | 0.98018365 |
| 118 | MP0001727_abnormal_embryo_implantation | 0.97491898 |
| 119 | MP0004782_abnormal_surfactant_physiolog | 0.95668486 |
| 120 | MP0000681_abnormal_thyroid_gland | 0.95493066 |
| 121 | MP0003634_abnormal_glial_cell | 0.94333968 |
| 122 | MP0001851_eye_inflammation | 0.93932193 |
| 123 | MP0005666_abnormal_adipose_tissue | 0.93569219 |
| 124 | MP0002138_abnormal_hepatobiliary_system | 0.93065416 |
| 125 | MP0009643_abnormal_urine_homeostasis | 0.92931860 |
| 126 | MP0005075_abnormal_melanosome_morpholog | 0.92774967 |
| 127 | MP0005395_other_phenotype | 0.91551877 |
| 128 | MP0000703_abnormal_thymus_morphology | 0.91207475 |
| 129 | MP0000613_abnormal_salivary_gland | 0.89386949 |
| 130 | MP0000778_abnormal_nervous_system | 0.88707797 |
| 131 | MP0003705_abnormal_hypodermis_morpholog | 0.88560247 |
| 132 | MP0003453_abnormal_keratinocyte_physiol | 0.87550203 |
| 133 | MP0008004_abnormal_stomach_pH | 0.87436604 |
| 134 | MP0004134_abnormal_chest_morphology | 0.87387026 |
| 135 | MP0002938_white_spotting | 0.86494753 |
| 136 | MP0001663_abnormal_digestive_system | 0.86150592 |
| 137 | MP0005076_abnormal_cell_differentiation | 0.85757002 |
| 138 | MP0006082_CNS_inflammation | 0.85490429 |
| 139 | MP0000609_abnormal_liver_physiology | 0.85434230 |
| 140 | MP0003941_abnormal_skin_development | 0.84917179 |
| 141 | MP0004808_abnormal_hematopoietic_stem | 0.83465359 |
| 142 | MP0005390_skeleton_phenotype | 0.82101931 |
| 143 | MP0005164_abnormal_response_to | 0.81683452 |
| 144 | MP0001542_abnormal_bone_strength | 0.80964006 |
| 145 | MP0002118_abnormal_lipid_homeostasis | 0.80802554 |
| 146 | MP0010678_abnormal_skin_adnexa | 0.80258676 |
| 147 | MP0009250_abnormal_appendicular_skeleto | 0.80138411 |
| 148 | MP0004185_abnormal_adipocyte_glucose | 0.79728882 |
| 149 | MP0000049_abnormal_middle_ear | 0.79373878 |
| 150 | MP0003656_abnormal_erythrocyte_physiolo | 0.79278274 |
| 151 | MP0001664_abnormal_digestion | 0.78754695 |
| 152 | MP0003878_abnormal_ear_physiology | 0.78388537 |
| 153 | MP0005377_hearing/vestibular/ear_phenot | 0.78388537 |
| 154 | MP0004885_abnormal_endolymph | 0.78368232 |
| 155 | MP0000647_abnormal_sebaceous_gland | 0.78208925 |
| 156 | MP0009384_cardiac_valve_regurgitation | 0.78157178 |
| 157 | MP0002752_abnormal_somatic_nervous | 0.77884904 |
| 158 | MP0001440_abnormal_grooming_behavior | 0.77694227 |
| 159 | MP0002254_reproductive_system_inflammat | 0.77634376 |
| 160 | MP0003091_abnormal_cell_migration | 0.77278233 |
| 161 | MP0003828_pulmonary_edema | 0.76220404 |
| 162 | MP0002249_abnormal_larynx_morphology | 0.76128040 |
| 163 | MP0000249_abnormal_blood_vessel | 0.75687015 |
| 164 | MP0004858_abnormal_nervous_system | 0.75245793 |
| 165 | MP0003045_fibrosis | 0.75203532 |
| 166 | MP0000762_abnormal_tongue_morphology | 0.73161629 |
| 167 | MP0003795_abnormal_bone_structure | 0.73045841 |
| 168 | MP0005375_adipose_tissue_phenotype | 0.73001491 |
| 169 | MP0005310_abnormal_salivary_gland | 0.72964619 |
| 170 | MP0000490_abnormal_crypts_of | 0.72689297 |
| 171 | MP0005595_abnormal_vascular_smooth | 0.72637160 |
| 172 | MP0005319_abnormal_enzyme/_coenzyme | 0.72612840 |
| 173 | MP0005423_abnormal_somatic_nervous | 0.72557502 |
| 174 | MP0004883_abnormal_blood_vessel | 0.71989046 |
| 175 | MP0008874_decreased_physiological_sensi | 0.71852445 |
| 176 | MP0002064_seizures | 0.70765330 |
| 177 | MP0003632_abnormal_nervous_system | 0.70203914 |
| 178 | MP0009763_increased_sensitivity_to | 0.70144452 |
| 179 | MP0002067_abnormal_sensory_capabilities | 0.69840233 |
| 180 | MP0005535_abnormal_body_temperature | 0.68121681 |
| 181 | MP0009046_muscle_twitch | 0.67963819 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Parakeratosis (HP:0001036) | 5.08820031 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.67370124 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.67370124 |
| 4 | Abnormality of glycolipid metabolism (HP:0010969) | 4.67370124 |
| 5 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 4.29823532 |
| 6 | Eczematoid dermatitis (HP:0000976) | 4.17408176 |
| 7 | Dysostosis multiplex (HP:0000943) | 4.16547972 |
| 8 | Increased cerebral lipofuscin (HP:0011813) | 4.15341868 |
| 9 | Abnormality of macrophages (HP:0004311) | 3.98666998 |
| 10 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.74971888 |
| 11 | Recurrent abscess formation (HP:0002722) | 3.70975188 |
| 12 | Systemic lupus erythematosus (HP:0002725) | 3.67287882 |
| 13 | Recurrent bacterial skin infections (HP:0005406) | 3.60710647 |
| 14 | Myositis (HP:0100614) | 3.58058811 |
| 15 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.36583615 |
| 16 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.36583615 |
| 17 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.36583615 |
| 18 | Loss of speech (HP:0002371) | 3.33551058 |
| 19 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.23068499 |
| 20 | Mucopolysacchariduria (HP:0008155) | 3.23068499 |
| 21 | Congenital ichthyosiform erythroderma (HP:0007431) | 3.22547910 |
| 22 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.18469257 |
| 23 | Orchitis (HP:0100796) | 3.17430198 |
| 24 | Prolonged neonatal jaundice (HP:0006579) | 3.14360594 |
| 25 | Hypomagnesemia (HP:0002917) | 3.12873645 |
| 26 | Prolonged partial thromboplastin time (HP:0003645) | 3.04524596 |
| 27 | Mediastinal lymphadenopathy (HP:0100721) | 3.03919275 |
| 28 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.03844991 |
| 29 | Chronic obstructive pulmonary disease (HP:0006510) | 2.99260466 |
| 30 | Obstructive lung disease (HP:0006536) | 2.99260466 |
| 31 | Cellulitis (HP:0100658) | 2.94763402 |
| 32 | Renal Fanconi syndrome (HP:0001994) | 2.89698080 |
| 33 | Purpura (HP:0000979) | 2.88303225 |
| 34 | Meningitis (HP:0001287) | 2.79607289 |
| 35 | Septo-optic dysplasia (HP:0100842) | 2.78674336 |
| 36 | 3-Methylglutaconic aciduria (HP:0003535) | 2.74604546 |
| 37 | Osteomalacia (HP:0002749) | 2.74063750 |
| 38 | Abnormality of the axillary hair (HP:0100134) | 2.73060011 |
| 39 | Abnormality of secondary sexual hair (HP:0009888) | 2.73060011 |
| 40 | Metabolic alkalosis (HP:0200114) | 2.70398300 |
| 41 | Petechiae (HP:0000967) | 2.69149357 |
| 42 | Acute necrotizing encephalopathy (HP:0006965) | 2.67596916 |
| 43 | Recurrent fungal infections (HP:0002841) | 2.67517012 |
| 44 | Colitis (HP:0002583) | 2.62828064 |
| 45 | Optic neuritis (HP:0100653) | 2.62602254 |
| 46 | Retrobulbar optic neuritis (HP:0100654) | 2.62602254 |
| 47 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.61810052 |
| 48 | Gastrointestinal stroma tumor (HP:0100723) | 2.60087387 |
| 49 | Abnormality of magnesium homeostasis (HP:0004921) | 2.59239104 |
| 50 | Hypophosphatemic rickets (HP:0004912) | 2.55969495 |
| 51 | Increased IgE level (HP:0003212) | 2.55189505 |
| 52 | Acute encephalopathy (HP:0006846) | 2.54325557 |
| 53 | Patchy hypopigmentation of hair (HP:0011365) | 2.53560318 |
| 54 | Amyloidosis (HP:0011034) | 2.53378202 |
| 55 | Glycosuria (HP:0003076) | 2.52107751 |
| 56 | Abnormality of urine glucose concentration (HP:0011016) | 2.52107751 |
| 57 | Spontaneous hematomas (HP:0007420) | 2.51432957 |
| 58 | Abnormality of renal resorption (HP:0011038) | 2.51352723 |
| 59 | J-shaped sella turcica (HP:0002680) | 2.49714450 |
| 60 | Recurrent viral infections (HP:0004429) | 2.49631764 |
| 61 | Generalized aminoaciduria (HP:0002909) | 2.48303481 |
| 62 | Proximal tubulopathy (HP:0000114) | 2.47740266 |
| 63 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.47608313 |
| 64 | Gastrointestinal inflammation (HP:0004386) | 2.47600829 |
| 65 | Vacuolated lymphocytes (HP:0001922) | 2.44835296 |
| 66 | Erythroderma (HP:0001019) | 2.44259447 |
| 67 | Recurrent skin infections (HP:0001581) | 2.43974586 |
| 68 | Increased serum ferritin (HP:0003281) | 2.43830642 |
| 69 | Agammaglobulinemia (HP:0004432) | 2.41794345 |
| 70 | Split foot (HP:0001839) | 2.41134765 |
| 71 | Vasculitis (HP:0002633) | 2.40700857 |
| 72 | Conjugated hyperbilirubinemia (HP:0002908) | 2.39527547 |
| 73 | Neurofibrillary tangles (HP:0002185) | 2.39419808 |
| 74 | Gingivitis (HP:0000230) | 2.38057618 |
| 75 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.37157275 |
| 76 | Inflammation of the large intestine (HP:0002037) | 2.36632855 |
| 77 | Stomatitis (HP:0010280) | 2.29326897 |
| 78 | White forelock (HP:0002211) | 2.28413969 |
| 79 | Vertebral compression fractures (HP:0002953) | 2.27164055 |
| 80 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.25004737 |
| 81 | Glomerulonephritis (HP:0000099) | 2.24962725 |
| 82 | Abnormality of complement system (HP:0005339) | 2.24900658 |
| 83 | Epistaxis (HP:0000421) | 2.24687540 |
| 84 | Prolonged bleeding time (HP:0003010) | 2.24617363 |
| 85 | Pulmonary infiltrates (HP:0002113) | 2.23483229 |
| 86 | Interstitial pulmonary disease (HP:0006530) | 2.23458815 |
| 87 | Nuclear cataract (HP:0100018) | 2.22179924 |
| 88 | Hypokalemic alkalosis (HP:0001949) | 2.20352330 |
| 89 | Axonal loss (HP:0003447) | 2.20184857 |
| 90 | Mitochondrial inheritance (HP:0001427) | 2.19038723 |
| 91 | Urticaria (HP:0001025) | 2.17938545 |
| 92 | Progressive macrocephaly (HP:0004481) | 2.16540445 |
| 93 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.15937036 |
| 94 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.15937036 |
| 95 | Pustule (HP:0200039) | 2.15122162 |
| 96 | Emphysema (HP:0002097) | 2.14476107 |
| 97 | Spastic paraparesis (HP:0002313) | 2.12382750 |
| 98 | Complement deficiency (HP:0004431) | 2.11887434 |
| 99 | Hypertensive crisis (HP:0100735) | 2.11624381 |
| 100 | Hypothermia (HP:0002045) | 2.10424336 |
| 101 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.10155431 |
| 102 | Thoracic kyphosis (HP:0002942) | 2.10149265 |
| 103 | Aplasia cutis congenita (HP:0001057) | 2.09519148 |
| 104 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.09171707 |
| 105 | Recurrent cutaneous fungal infections (HP:0011370) | 2.09171707 |
| 106 | Conical tooth (HP:0000698) | 2.08970806 |
| 107 | Methylmalonic acidemia (HP:0002912) | 2.08762404 |
| 108 | Abnormality of iron homeostasis (HP:0011031) | 2.08589756 |
| 109 | Rickets (HP:0002748) | 2.06930988 |
| 110 | Intrahepatic cholestasis (HP:0001406) | 2.06839183 |
| 111 | Increased hepatocellular lipid droplets (HP:0006565) | 2.06090573 |
| 112 | Optic disc pallor (HP:0000543) | 2.04166405 |
| 113 | Synostosis involving the elbow (HP:0003938) | 2.04047982 |
| 114 | Humeroradial synostosis (HP:0003041) | 2.04047982 |
| 115 | Increased circulating renin level (HP:0000848) | 2.03955333 |
| 116 | Metaphyseal irregularity (HP:0003025) | 2.03892794 |
| 117 | Hemorrhage of the eye (HP:0011885) | 2.02700363 |
| 118 | Neuronal loss in central nervous system (HP:0002529) | 2.00310394 |
| 119 | Cerebral aneurysm (HP:0004944) | 2.00276732 |
| 120 | Symptomatic seizures (HP:0011145) | 2.00225264 |
| 121 | Cerebral edema (HP:0002181) | 1.98980673 |
| 122 | Encephalitis (HP:0002383) | 1.98887092 |
| 123 | Polygenic inheritance (HP:0010982) | 1.97026459 |
| 124 | Asymmetric septal hypertrophy (HP:0001670) | 1.96842677 |
| 125 | Osteomyelitis (HP:0002754) | 1.96603173 |
| 126 | Nasolacrimal duct obstruction (HP:0000579) | 1.95682312 |
| 127 | Lipid accumulation in hepatocytes (HP:0006561) | 1.95399582 |
| 128 | Renal tubular dysfunction (HP:0000124) | 1.95398189 |
| 129 | Gingival bleeding (HP:0000225) | 1.95336599 |
| 130 | Restrictive lung disease (HP:0002091) | 1.94153944 |
| 131 | Gastrointestinal infarctions (HP:0005244) | 1.92879149 |
| 132 | Abnormal urine phosphate concentration (HP:0012599) | 1.92206219 |
| 133 | Optic nerve hypoplasia (HP:0000609) | 1.90047427 |
| 134 | Chest pain (HP:0100749) | 1.90044098 |
| 135 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.89667561 |
| 136 | Progressive neurologic deterioration (HP:0002344) | 1.89536243 |
| 137 | Hemoptysis (HP:0002105) | 1.88523373 |
| 138 | Joint hemorrhage (HP:0005261) | 1.87442856 |
| 139 | Hepatosplenomegaly (HP:0001433) | 1.86676549 |
| 140 | Absent septum pellucidum (HP:0001331) | 1.85972893 |
| 141 | Abnormality of the thoracic spine (HP:0100711) | 1.84957354 |
| 142 | Congenital sensorineural hearing impairment (HP:0008527) | 1.83277248 |
| 143 | Hypertriglyceridemia (HP:0002155) | 1.82905228 |
| 144 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.82807294 |
| 145 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.82651666 |
| 146 | Panhypogammaglobulinemia (HP:0003139) | 1.82211623 |
| 147 | Granulocytopenia (HP:0001913) | 1.82115206 |
| 148 | Duplication of thumb phalanx (HP:0009942) | 1.81401756 |
| 149 | Methylmalonic aciduria (HP:0012120) | 1.81113666 |
| 150 | Lymphopenia (HP:0001888) | 1.80592050 |
| 151 | Pulmonary embolism (HP:0002204) | 1.80272569 |
| 152 | Keratoconjunctivitis sicca (HP:0001097) | 1.80015360 |
| 153 | Alkalosis (HP:0001948) | 1.79313637 |
| 154 | Adrenal hypoplasia (HP:0000835) | 1.79234705 |
| 155 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.79198361 |
| 156 | Fatigue (HP:0012378) | 1.79009077 |
| 157 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.78725393 |
| 158 | Fibular aplasia (HP:0002990) | 1.78086217 |
| 159 | Leukodystrophy (HP:0002415) | 1.76884294 |
| 160 | Myocardial infarction (HP:0001658) | 1.76746697 |
| 161 | Lethargy (HP:0001254) | 1.76633339 |
| 162 | Joint stiffness (HP:0001387) | 1.76603074 |
| 163 | Arthralgia (HP:0002829) | 1.76141424 |
| 164 | Cardiomegaly (HP:0001640) | 1.76089288 |
| 165 | Deep venous thrombosis (HP:0002625) | 1.75940995 |
| 166 | Episodic fever (HP:0001954) | 1.75605959 |
| 167 | Premature loss of primary teeth (HP:0006323) | 1.75559063 |
| 168 | Thrombocytosis (HP:0001894) | 1.75473532 |
| 169 | Hypophosphatemia (HP:0002148) | 1.75292586 |
| 170 | Autoimmune thrombocytopenia (HP:0001973) | 1.74606285 |
| 171 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.74594874 |
| 172 | Short tibia (HP:0005736) | 1.73747165 |
| 173 | Retinal dysplasia (HP:0007973) | 1.73617779 |
| 174 | Renal cortical cysts (HP:0000803) | 1.73416187 |
| 175 | Hyperaldosteronism (HP:0000859) | 1.73153059 |
| 176 | Tetany (HP:0001281) | 1.73119841 |
| 177 | Hyperventilation (HP:0002883) | 1.72978698 |
| 178 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.70939367 |
| 179 | Absent/shortened dynein arms (HP:0200106) | 1.70939367 |
| 180 | Abnormality of the septum pellucidum (HP:0007375) | 1.70767907 |
| 181 | Aplasia of the musculature (HP:0100854) | 1.70728117 |
| 182 | Abnormality of renin-angiotensin system (HP:0000847) | 1.70468861 |
| 183 | Dicarboxylic aciduria (HP:0003215) | 1.70296559 |
| 184 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.70296559 |
| 185 | Abnormality of methionine metabolism (HP:0010901) | 1.70052543 |
| 186 | Hyperlipoproteinemia (HP:0010980) | 1.69980870 |
| 187 | Abnormality of chloride homeostasis (HP:0011422) | 1.69766045 |
| 188 | Hyperactive renin-angiotensin system (HP:0000841) | 1.69110015 |
| 189 | Abnormality of glycine metabolism (HP:0010895) | 1.67898718 |
| 190 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.67898718 |
| 191 | Limb dystonia (HP:0002451) | 1.66455994 |
| 192 | Polyuria (HP:0000103) | 1.66298763 |
| 193 | Anomalous pulmonary venous return (HP:0010772) | 1.64429042 |
| 194 | Widely patent fontanelles and sutures (HP:0004492) | 1.64393070 |
| 195 | Hypoplastic pelvis (HP:0008839) | 1.63729767 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.34752919 |
| 2 | CASK | 3.72755078 |
| 3 | MAP4K1 | 3.40381509 |
| 4 | STK39 | 3.19207942 |
| 5 | TRIB3 | 2.86676707 |
| 6 | INSRR | 2.84835585 |
| 7 | RIPK4 | 2.83629763 |
| 8 | OXSR1 | 2.80678469 |
| 9 | IRAK3 | 2.59128546 |
| 10 | MAP2K3 | 2.47437140 |
| 11 | IRAK2 | 2.36983441 |
| 12 | BLK | 2.35406543 |
| 13 | STK16 | 2.31520019 |
| 14 | IRAK4 | 2.30463083 |
| 15 | TYK2 | 2.19495638 |
| 16 | SIK1 | 2.16166135 |
| 17 | IRAK1 | 2.09128445 |
| 18 | TNK2 | 2.08059699 |
| 19 | TNIK | 2.07272057 |
| 20 | PKN1 | 2.04997095 |
| 21 | WNK4 | 2.03451725 |
| 22 | EPHB1 | 2.02717906 |
| 23 | PBK | 2.01293602 |
| 24 | NME2 | 1.94204040 |
| 25 | TBK1 | 1.88679062 |
| 26 | MAP3K11 | 1.87348915 |
| 27 | MUSK | 1.83222359 |
| 28 | PNCK | 1.77678493 |
| 29 | PRPF4B | 1.75375554 |
| 30 | SMG1 | 1.74853036 |
| 31 | MAPK15 | 1.72157621 |
| 32 | ADRBK2 | 1.70480121 |
| 33 | ICK | 1.70346412 |
| 34 | MKNK2 | 1.68491154 |
| 35 | MAP3K3 | 1.68235214 |
| 36 | NEK6 | 1.61712789 |
| 37 | ZAP70 | 1.58650168 |
| 38 | MAP3K14 | 1.52019408 |
| 39 | WNK3 | 1.51770759 |
| 40 | MAPKAPK5 | 1.47005175 |
| 41 | TAOK2 | 1.46246584 |
| 42 | AKT3 | 1.43418750 |
| 43 | MAP3K1 | 1.41411731 |
| 44 | BMPR1B | 1.39759784 |
| 45 | GRK1 | 1.36612138 |
| 46 | JAK3 | 1.33443422 |
| 47 | PRKD2 | 1.31086179 |
| 48 | TAOK1 | 1.31004697 |
| 49 | GRK7 | 1.30161461 |
| 50 | RIPK1 | 1.29614156 |
| 51 | ERBB4 | 1.29408184 |
| 52 | EPHA2 | 1.27824440 |
| 53 | BTK | 1.25994859 |
| 54 | BMPR2 | 1.23918421 |
| 55 | ZAK | 1.23714899 |
| 56 | GRK6 | 1.22782094 |
| 57 | EEF2K | 1.21787551 |
| 58 | MARK2 | 1.20019257 |
| 59 | KIT | 1.18760856 |
| 60 | CSK | 1.18176743 |
| 61 | CSF1R | 1.16780202 |
| 62 | MET | 1.16697139 |
| 63 | FGFR4 | 1.14757415 |
| 64 | PTK6 | 1.14446729 |
| 65 | SIK2 | 1.14273066 |
| 66 | FGR | 1.11376138 |
| 67 | SYK | 1.10909962 |
| 68 | CDC42BPA | 1.09483566 |
| 69 | STK38L | 1.08053845 |
| 70 | EPHA3 | 1.04410875 |
| 71 | BCR | 1.03658520 |
| 72 | MAP2K6 | 1.02331494 |
| 73 | PRKCE | 1.00136807 |
| 74 | MKNK1 | 0.99015219 |
| 75 | DYRK2 | 0.98157574 |
| 76 | PDPK1 | 0.97753783 |
| 77 | MST4 | 0.97711471 |
| 78 | PINK1 | 0.96967212 |
| 79 | CAMK2B | 0.96824078 |
| 80 | JAK1 | 0.96530811 |
| 81 | TESK2 | 0.95620342 |
| 82 | EIF2AK2 | 0.95584270 |
| 83 | TGFBR2 | 0.94944646 |
| 84 | CAMK2D | 0.94632522 |
| 85 | YES1 | 0.94343241 |
| 86 | MATK | 0.91899738 |
| 87 | HCK | 0.90835515 |
| 88 | SIK3 | 0.85290634 |
| 89 | CLK1 | 0.84772844 |
| 90 | NLK | 0.84622600 |
| 91 | TXK | 0.83658638 |
| 92 | MAPK12 | 0.82453816 |
| 93 | CSNK1G3 | 0.81910527 |
| 94 | MAP3K7 | 0.81586625 |
| 95 | PDK1 | 0.80815121 |
| 96 | MAPK11 | 0.79753042 |
| 97 | WNK1 | 0.78680691 |
| 98 | JAK2 | 0.78554484 |
| 99 | PLK4 | 0.78309190 |
| 100 | CAMK2G | 0.78110437 |
| 101 | CSNK1A1L | 0.76725727 |
| 102 | SGK223 | 0.75766731 |
| 103 | SGK494 | 0.75766731 |
| 104 | TRPM7 | 0.75745834 |
| 105 | MARK3 | 0.74994851 |
| 106 | CDK12 | 0.73967896 |
| 107 | CSNK1G1 | 0.73732039 |
| 108 | KSR2 | 0.73160350 |
| 109 | TESK1 | 0.72856477 |
| 110 | PKN2 | 0.70901612 |
| 111 | CAMK2A | 0.68700160 |
| 112 | NME1 | 0.67963639 |
| 113 | MAP3K13 | 0.67711162 |
| 114 | ITK | 0.66608584 |
| 115 | LCK | 0.66135424 |
| 116 | ROCK2 | 0.65549576 |
| 117 | DAPK2 | 0.65411730 |
| 118 | RPS6KL1 | 0.63513007 |
| 119 | RPS6KC1 | 0.63513007 |
| 120 | BMX | 0.62408026 |
| 121 | MARK1 | 0.62352896 |
| 122 | PIK3CG | 0.62065066 |
| 123 | DDR2 | 0.60679930 |
| 124 | RPS6KA2 | 0.60659956 |
| 125 | LRRK2 | 0.60364129 |
| 126 | CDK3 | 0.59351010 |
| 127 | MST1R | 0.59254561 |
| 128 | TIE1 | 0.57537027 |
| 129 | PRKD3 | 0.56015540 |
| 130 | IKBKB | 0.55077488 |
| 131 | TAOK3 | 0.54151682 |
| 132 | RPS6KA5 | 0.53966413 |
| 133 | STK10 | 0.50899986 |
| 134 | VRK1 | 0.50855403 |
| 135 | BCKDK | 0.50416995 |
| 136 | RPS6KA6 | 0.50197431 |
| 137 | CSNK1G2 | 0.50179471 |
| 138 | BRAF | 0.50087001 |
| 139 | ABL2 | 0.49950794 |
| 140 | IKBKE | 0.49660700 |
| 141 | PRKCQ | 0.48294762 |
| 142 | PRKG1 | 0.47343555 |
| 143 | PRKG2 | 0.46181489 |
| 144 | PIK3CA | 0.46166786 |
| 145 | PIM2 | 0.46080346 |
| 146 | STK38 | 0.45849560 |
| 147 | DYRK1B | 0.45666730 |
| 148 | ARAF | 0.45309070 |
| 149 | MAP2K2 | 0.44014282 |
| 150 | FGFR3 | 0.43776962 |
| 151 | HIPK2 | 0.42337581 |
| 152 | CDK4 | 0.41925583 |
| 153 | PRKACA | 0.41394445 |
| 154 | MAP3K8 | 0.39068215 |
| 155 | MOS | 0.38989601 |
| 156 | MAPKAPK2 | 0.37802474 |
| 157 | TEC | 0.37683001 |
| 158 | PRKAA2 | 0.37629942 |
| 159 | LYN | 0.37409489 |
| 160 | CSNK1A1 | 0.36963935 |
| 161 | PAK3 | 0.36658083 |
| 162 | PAK4 | 0.36567977 |
| 163 | LMTK2 | 0.36220891 |
| 164 | FGFR2 | 0.36164987 |
| 165 | FES | 0.35851626 |
| 166 | MYLK | 0.35823443 |
| 167 | RET | 0.35641591 |
| 168 | MAPK4 | 0.35045459 |
| 169 | EPHA4 | 0.34891444 |
| 170 | MTOR | 0.34581168 |
| 171 | CAMKK1 | 0.33967453 |
| 172 | MAPK7 | 0.33500830 |
| 173 | ADRBK1 | 0.32973031 |
| 174 | MAP3K6 | 0.32440527 |
| 175 | FER | 0.32361191 |
| 176 | GRK5 | 0.31185626 |
| 177 | SRPK1 | 0.29698772 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fatty acid elongation_Homo sapiens_hsa00062 | 3.38147834 |
| 2 | Steroid biosynthesis_Homo sapiens_hsa00100 | 3.31853980 |
| 3 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.01747764 |
| 4 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.95644503 |
| 5 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.69983369 |
| 6 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.54143396 |
| 7 | Leishmaniasis_Homo sapiens_hsa05140 | 2.43509330 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.39100130 |
| 9 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.33681994 |
| 10 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.31589608 |
| 11 | Protein export_Homo sapiens_hsa03060 | 2.26653157 |
| 12 | Histidine metabolism_Homo sapiens_hsa00340 | 2.20777908 |
| 13 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 2.18204560 |
| 14 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.12344560 |
| 15 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.11580883 |
| 16 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.02755237 |
| 17 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.02133306 |
| 18 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.96558616 |
| 19 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.85991103 |
| 20 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.84979965 |
| 21 | Parkinsons disease_Homo sapiens_hsa05012 | 1.81008520 |
| 22 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.79627032 |
| 23 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.79170388 |
| 24 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.77085311 |
| 25 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.77072679 |
| 26 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.76246111 |
| 27 | Tuberculosis_Homo sapiens_hsa05152 | 1.75769457 |
| 28 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.70714552 |
| 29 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.67797161 |
| 30 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.67545153 |
| 31 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.63591985 |
| 32 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.61612829 |
| 33 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.60122067 |
| 34 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.60115035 |
| 35 | Other glycan degradation_Homo sapiens_hsa00511 | 1.59169796 |
| 36 | Peroxisome_Homo sapiens_hsa04146 | 1.58646168 |
| 37 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.58002651 |
| 38 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.55077803 |
| 39 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.53160752 |
| 40 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.51895866 |
| 41 | Alzheimers disease_Homo sapiens_hsa05010 | 1.51809848 |
| 42 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.51432611 |
| 43 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.51075494 |
| 44 | Retinol metabolism_Homo sapiens_hsa00830 | 1.50555096 |
| 45 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.47544922 |
| 46 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.46564154 |
| 47 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.46421084 |
| 48 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.46181421 |
| 49 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.45770001 |
| 50 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.40912761 |
| 51 | RNA polymerase_Homo sapiens_hsa03020 | 1.37510697 |
| 52 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.37344765 |
| 53 | Influenza A_Homo sapiens_hsa05164 | 1.34974858 |
| 54 | Pertussis_Homo sapiens_hsa05133 | 1.30846172 |
| 55 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.29902925 |
| 56 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.26652368 |
| 57 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.23999657 |
| 58 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.23579705 |
| 59 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.23493771 |
| 60 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.20535308 |
| 61 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.19832832 |
| 62 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.19281872 |
| 63 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.18023716 |
| 64 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.16655432 |
| 65 | Viral myocarditis_Homo sapiens_hsa05416 | 1.14235356 |
| 66 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.13321074 |
| 67 | Huntingtons disease_Homo sapiens_hsa05016 | 1.13096660 |
| 68 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.11113099 |
| 69 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.11055144 |
| 70 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.09918789 |
| 71 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.07927484 |
| 72 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.07171539 |
| 73 | Galactose metabolism_Homo sapiens_hsa00052 | 1.06864188 |
| 74 | Hepatitis C_Homo sapiens_hsa05160 | 1.02449058 |
| 75 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.01922284 |
| 76 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.01815040 |
| 77 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.01596479 |
| 78 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.00290184 |
| 79 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.00067644 |
| 80 | Measles_Homo sapiens_hsa05162 | 0.99498694 |
| 81 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.99231719 |
| 82 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.98935846 |
| 83 | Hepatitis B_Homo sapiens_hsa05161 | 0.96070931 |
| 84 | ABC transporters_Homo sapiens_hsa02010 | 0.95347667 |
| 85 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.95120296 |
| 86 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.92476955 |
| 87 | Metabolic pathways_Homo sapiens_hsa01100 | 0.92225293 |
| 88 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.92152833 |
| 89 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.91964180 |
| 90 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.91700980 |
| 91 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.91530365 |
| 92 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.87709115 |
| 93 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.87367231 |
| 94 | Prion diseases_Homo sapiens_hsa05020 | 0.87319812 |
| 95 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.86108735 |
| 96 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.83903772 |
| 97 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.83529590 |
| 98 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.83499209 |
| 99 | Apoptosis_Homo sapiens_hsa04210 | 0.83314882 |
| 100 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.82899277 |
| 101 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.81989356 |
| 102 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.80189690 |
| 103 | Lysosome_Homo sapiens_hsa04142 | 0.78817590 |
| 104 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.78247299 |
| 105 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.77867251 |
| 106 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.77611715 |
| 107 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.76518680 |
| 108 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.76507269 |
| 109 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.76441374 |
| 110 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.76182171 |
| 111 | Bladder cancer_Homo sapiens_hsa05219 | 0.75549739 |
| 112 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.74868102 |
| 113 | Platelet activation_Homo sapiens_hsa04611 | 0.73501868 |
| 114 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.72895040 |
| 115 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.72502305 |
| 116 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.71262103 |
| 117 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.71197409 |
| 118 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.70903001 |
| 119 | Salmonella infection_Homo sapiens_hsa05132 | 0.69486085 |
| 120 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.68566748 |
| 121 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.68105910 |
| 122 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.65991877 |
| 123 | Taste transduction_Homo sapiens_hsa04742 | 0.65279432 |
| 124 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.64042773 |
| 125 | Mineral absorption_Homo sapiens_hsa04978 | 0.62727216 |
| 126 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.62314484 |
| 127 | Endocytosis_Homo sapiens_hsa04144 | 0.60443873 |
| 128 | Legionellosis_Homo sapiens_hsa05134 | 0.60359360 |
| 129 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.59760220 |
| 130 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.59615608 |
| 131 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.59032493 |
| 132 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.58891089 |
| 133 | Phototransduction_Homo sapiens_hsa04744 | 0.57823754 |
| 134 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.56716751 |
| 135 | Insulin resistance_Homo sapiens_hsa04931 | 0.56231410 |
| 136 | Shigellosis_Homo sapiens_hsa05131 | 0.55965154 |
| 137 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.55606713 |
| 138 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.55154363 |
| 139 | Amoebiasis_Homo sapiens_hsa05146 | 0.53525349 |
| 140 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.52673742 |
| 141 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.52502978 |
| 142 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.52256407 |
| 143 | HTLV-I infection_Homo sapiens_hsa05166 | 0.51963259 |
| 144 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.51184571 |
| 145 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.48642086 |
| 146 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.48628331 |
| 147 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.46672878 |
| 148 | Phagosome_Homo sapiens_hsa04145 | 0.46164765 |
| 149 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.45198646 |
| 150 | Proteasome_Homo sapiens_hsa03050 | 0.45112392 |
| 151 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.44056304 |
| 152 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.41859396 |
| 153 | Malaria_Homo sapiens_hsa05144 | 0.40831027 |
| 154 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.40611452 |
| 155 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.39713123 |
| 156 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.39660292 |
| 157 | Nicotine addiction_Homo sapiens_hsa05033 | 0.37181167 |
| 158 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.36700835 |
| 159 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.36299981 |
| 160 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.35123447 |
| 161 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.34882703 |
| 162 | Axon guidance_Homo sapiens_hsa04360 | 0.34010805 |
| 163 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.33862032 |
| 164 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.32376347 |
| 165 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.32326185 |
| 166 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.32200856 |
| 167 | Allograft rejection_Homo sapiens_hsa05330 | 0.30888900 |
| 168 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.30345392 |
| 169 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.29212263 |
| 170 | Sulfur relay system_Homo sapiens_hsa04122 | 0.28138252 |
| 171 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.28013733 |
| 172 | Purine metabolism_Homo sapiens_hsa00230 | 0.23936264 |
| 173 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.22382943 |
| 174 | Asthma_Homo sapiens_hsa05310 | 0.20708305 |
| 175 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.20070950 |

